163 related articles for article (PubMed ID: 23687794)
21. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
Sweis RF; Galsky MD
Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
[TBL] [Abstract][Full Text] [Related]
22. Re: Adjuvant Cisplatin-Based Combined Chemotherapy for Lymph Node (LN)-Positive Urothelial Carcinoma of the Bladder (UCB) after Radical Cystectomy (RC): A Retrospective International Study of >1500 Patients.
Chang SS
J Urol; 2016 Feb; 195(2):300. PubMed ID: 26852970
[No Abstract] [Full Text] [Related]
23. Adjuvant chemotherapy of bladder cancer.
Freiha FS; Torti FM
Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
[No Abstract] [Full Text] [Related]
24. Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder.
Sadeghi S; Garcia JA
Semin Oncol; 2012 Oct; 39(5):608-14. PubMed ID: 23040257
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?
Mazhar D; Ali N; Ngan S
Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495
[No Abstract] [Full Text] [Related]
26. Determining superior first-line therapy in metastatic bladder cancer.
Apolo AB
Nat Rev Urol; 2019 Dec; 16(12):698-699. PubMed ID: 31558843
[No Abstract] [Full Text] [Related]
27. Targeting Signaling Transduction Pathways in Bladder Cancer.
Abbosh PH; McConkey DJ; Plimack ER
Curr Oncol Rep; 2015 Dec; 17(12):58. PubMed ID: 26472299
[TBL] [Abstract][Full Text] [Related]
28. Systemic therapy of bladder cancer.
Salem PA
Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
[No Abstract] [Full Text] [Related]
29. New assay for cytotoxic agents in human bladder cancer.
Hagen K; Daly JJ; Kamali HM; Lin JC; Yu SC; Prout GR
Surg Forum; 1979; 30():560-2. PubMed ID: 538695
[No Abstract] [Full Text] [Related]
30. Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and Review.
Al-Marrawi MY; Mackley HB; Ali S; Wagner H; Joshi M; Holder S; Kaag M; Mallon C; Talamo G; Drabick JJ
Clin Genitourin Cancer; 2016 Aug; 14(4):e393-9. PubMed ID: 26877063
[No Abstract] [Full Text] [Related]
31. p53 and treatment of bladder cancer.
Cote RJ; Esrig D; Groshen S; Jones PA; Skinner DG
Nature; 1997 Jan; 385(6612):123-5. PubMed ID: 8990112
[No Abstract] [Full Text] [Related]
32. Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate.
Seligman PA; Crawford ED
J Natl Cancer Inst; 1991 Nov; 83(21):1582-4. PubMed ID: 1960756
[No Abstract] [Full Text] [Related]
33. Editorial comment.
Galsky MD
J Urol; 2012 Oct; 188(4):1114. PubMed ID: 22901587
[No Abstract] [Full Text] [Related]
34. p53 status in locally advanced bladder cancer.
Dizdar O; Demirci U
J Clin Oncol; 2012 Jan; 30(3):339; author reply 339-40. PubMed ID: 22184388
[No Abstract] [Full Text] [Related]
35. Intravesical chemotherapy.
Prout GR
Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
[No Abstract] [Full Text] [Related]
36. [Drug sensitivity test of cultured human bladder cancer cells].
Sekiguchi H
Nihon Hinyokika Gakkai Zasshi; 1983 Jan; 74(1):25-31. PubMed ID: 6865150
[No Abstract] [Full Text] [Related]
37. Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises.
Aragon-Ching JB; Trump DL
Future Oncol; 2016 Sep; 12(17):2049-58. PubMed ID: 27306417
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study on the effectiveness of sequential administration of chemotherapeutic agents in bladder cancer].
Afuso H
Nihon Hinyokika Gakkai Zasshi; 1984 Aug; 75(8):1244-51. PubMed ID: 6513224
[No Abstract] [Full Text] [Related]
39. Risk-adapted use of intravesical chemotherapy.
Lerner SP; Au JL
BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889
[No Abstract] [Full Text] [Related]
40. Chemotherapy for advanced transitional cell carcinoma of the urothelium: cisplatin or carboplatin?
Culine S
Eur Urol; 2007 Jul; 52(1):9-10. PubMed ID: 17239527
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
